[SMARCA4]

Lishan Peng1, Wenzhao Zhong1

  • 1Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), 
Southern Medical University, Guangzhou 510080, China.

概括

关键的瘤抑制基因SMARCA4的突变与非小细胞肺癌 (NSCLC) 的不良预后有关. 了解这些突变对于开发针对这种致命疾病的新治疗策略至关重要.